Site icon pharmaceutical daily

Certara to Participate in Upcoming Investor Conferences

PRINCETON, N.J., Aug. 31, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the following virtual investor conferences: Morgan Stanley 19th Annual Global Healthcare ConferenceDate and Time: Tuesday, September 14 at 9:30 a.m. ETSpeakers: William Feehery, chief executive officer, and Andrew Schemick, chief financial officer Baird 2021 Global Healthcare ConferenceDate and Time: Wednesday, September 15 at 4:55 p.m. ETSpeaker: Andrew Schemick, chief financial officer Bank of America Securities 2021 Tech Solutions for Drug Discovery ConferenceDate and Time: Monday, September 20 at 8:00 a.m. ETSpeakers: William Feehery, chief executive officer, and Andrew Schemick, chief financial officer Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter. About CertaraCertara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Investor Relations Contact:David DeuchlerGilmartin Groupir@certara.com Media Contact:Ariane LovellFinn Partnersariane.lovell@finnpartners.com 

Exit mobile version